Leg Ulcer
1
Pipeline Programs
3
Companies
4
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
1
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
ConvaTecNJ - Bridgewater
3 programsEASH dressingPHASE_21 trial
AQUACEL®PHASE_31 trial
AQUACEL® AgPHASE_41 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
ConvaTecAQUACEL® Ag
ConvaTecAQUACEL®
ConvaTecEASH dressing
BioTherapeutics IncNitric Oxide
Clinical Trials (4)
Total enrollment: 391 patients across 4 trials
AQUACEL® Ag Dressing and Urgotul® Silver Dressing on Healing of Chronic Venous Leg Ulcers
Start: Jan 2010Est. completion: Jan 2011266 patients
Phase 4Completed
Study to Evaluate the Performance of AQUACEL® Extra™ in Venous Leg Ulcers
Start: May 2012Est. completion: Sep 201265 patients
Phase 3Completed
EASH Dressing on Chronic Venous Leg Ulcers
Start: Nov 2011Est. completion: Apr 201240 patients
Phase 2Completed
Reduction of Bacteria in MRSA Positive Ulcers
Start: Jan 2009Est. completion: Jun 200920 patients
Phase 1/2Terminated
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
3 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.